Dexlansoprazole for Injection(Jiangsu Aosaikang Pharma)

注射用右兰索拉唑(江苏奥赛康药业)

Report date: 2026/04/08 15:33:12

Base Information

Drug NameDexlansoprazole for Injection(Jiangsu Aosaikang Pharma)
Drug Alias Namedexlansoprazolum右旋兰索拉唑dexlansoprazol注射用右旋兰索拉唑(江苏奥赛康药业)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProton pump inhibitors
TargetsProton pump
Therapy Area/IndicationsStomach UlcerDuodenal UlcerPeptic Ulcer Hemorrhage +[4
Global Approved IndicationsStomach UlcerDuodenal Ulcer
Approved Indications in ChinaStomach UlcerDuodenal Ulcer
Original Approved Country/TerritoryMainland China
Original Approved Date2024/01/09
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Active IndicationsStomach UlcerDuodenal Ulcer
Inactive IndicationsPeptic Ulcer HemorrhageGastrointestinal Hemorrhage

Other Information

ATC CodeN/A